Advertisement

Reactions Weekly

, Volume 1635, Issue 1, pp 75–75 | Cite as

Ceritinib/crizotinib

Development of resistance in EML4-ALK-positive non-small cell lung cancer: case report
Case report
  • 17 Downloads

Reference

  1. Aieta M, et al. Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC). Clinical Lung Cancer 17: e173-e177, No. 5, Sep 2016. Available from: URL: http://doi.org/10.1016/j.cllc.2016.05.002 - ItalyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations